Mortality indicators in pneumococcal meningitis: therapeutic implications
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The aim of this study was to delineate mortality indicators in pneumococcal meningitis with special emphasis on therapeutic implications. METHODS: This retrospective, multicenter cohort study involved a 15-year period (1998-2012). Culture-positive cases (n=306) were included solely from 38 centers. RESULTS: Fifty-eight patients received ceftriaxone plus vancomycin empirically. The rest were given a third-generation cephalosporin alone. Overall, 246 (79.1%) isolates were found to be penicillin-susceptible, 38 (12.2%) strains were penicillin-resistant, and 22 (7.1%) were oxacillin-resistant (without further minimum inhibitory concentration testing for penicillin). Being a critical case (odds ratio (OR) 7.089, 95% confidence interval (CI) 3.230-15.557) and age over 50 years (OR 3.908, 95% CI 1.820-8.390) were independent predictors of mortality, while infection with a penicillin-susceptible isolate (OR 0.441, 95% CI 0.195-0.996) was found to be protective. Empirical vancomycin use did not provide significant benefit (OR 2.159, 95% CI 0.949-4.912). CONCLUSIONS: Ceftriaxone alone is not adequate in the management of pneumococcal meningitis due to penicillin-resistant pneumococci, which is a major concern worldwide. Although vancomycin showed a trend towards improving the prognosis of pneumococcal meningitis, significant correlation in statistical terms could not be established in this study. Thus, further studies are needed for the optimization of pneumococcal meningitis treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practice Guidelines for the Management of Bacterial Meningitis
Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., & Whitley, R. J. (2004) · Clinical Infectious Diseases · doi:10.1086/425368 · Cited by 2,308 · cited 2×
“Adding rifampin to other antibiotics in the management of pneumococcal meningitis is another option in cases where vancomycin has the potential to fail.(7) Further studies are also needed on daptomycin and newer glycopeptides to determine their place in the management of pneumococcal meningitis.”
BackgroundClinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344
Cited by
ESCMID guideline: diagnosis and treatment of acute bacterial meningitis
van de Beek, D., Cabellos, C., Dzupova, O., Esposito, S., Klein, M., Kloek, A. T., Leib, S. L., Mourvillier, B., Ostergaard, C., Pagliano, P., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.01.007 · Cited by 919
Acute bacterial meningitis in adults
McGill, F., Heyderman, R. S., Panagiotou, S., Tunkel, A. R., & Solomon, T. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30654-7 · Cited by 274
Erdem, H., Cag, Y., Ozturk-Engin, D., Defres, S., Kaya, S., Larsen, L., Poljak, M., Barsic, B., Argemi, X., Sørensen, S. M., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05016-14 · Cited by 74
Self-citationPopescu, C. P., Florescu, S. A., Hasbun, R., Harxhi, A., Evendar, R., Kahraman, H., Neuberger, A., Codreanu, D., Zaharia, M. F., Tosun, S., et al. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2019.104213 · Cited by 28
Self-citation
Metadata
- Authors
- Erdem, H., Elaldi, N., Öztoprak, N., Sengoz, G., Ak, O., Kaya, S., Inan, A., Nayman-Alpat, S., Ulu-Kilic, A., Pekok, A. U., Gunduz, A., Gozel, M. G., Pehlivanoglu, F., Yasar, K., Yılmaz, H., Hatipoglu, M., Cicek-Senturk, G., Akcam, F. Z., Inkaya, A. C., Kazak, E., Sagmak-Tartar, A., Tekin, R., Ozturk-Engin, D., Ersoy, Y., Sipahi, O. R., Guven, T., Tuncer-Ertem, G., Alabay, S., Akbulut, A., Balkan, I. I., Oncul, O., Cetin, B., Dayan, S., Ersoz, G., Karakas, A., Ozgunes, N., Sener, A., Yesilkaya, A., Erturk, A., Gundes, S., Karabay, O., Sirmatel, F., Tosun, S., Turhan, V., Yalci, A., Akkoyunlu, Y., Aydın, E., Diktas, H., Kose, S., Ulcay, A., Seyman, D., Savasci, U., Leblebicioglu, H., & Vahaboglu, H.
- Venue
- International Journal of Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2014-02
- Volume
- 19
- Pages
- 13-19
- ISSN
- 1201-9712 (ISSN-L)
- OpenAlex
- W2018166454
- Cited by
- 49
- References
- 3
- FWCI
- 2.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Mortality indicators in pneumococcal meningitis: therapeutic implications. https://app.cochat.ai/papers/10.1016/j.ijid.2013.09.012
- The paper
- Erdem, H., Elaldi, N., Öztoprak, N., Sengoz, G., Ak, O., Kaya, S., Inan, A., Nayman-Alpat, S., Ulu-Kilic, A., Pekok, A. U., Gunduz, A., Gozel, M. G., Pehlivanoglu, F., Yasar, K., Yılmaz, H., Hatipoglu, M., Cicek-Senturk, G., Akcam, F. Z., Inkaya, A. C., . . . Vahaboglu, H. (2014). Mortality indicators in pneumococcal meningitis: therapeutic implications. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2013.09.012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.